218 related articles for article (PubMed ID: 37242599)
21. Comparative study of extracellular vesicles derived from mesenchymal stem cells and brain endothelial cells attenuating blood-brain barrier permeability via regulating Caveolin-1-dependent ZO-1 and Claudin-5 endocytosis in acute ischemic stroke.
Li Y; Liu B; Zhao T; Quan X; Han Y; Cheng Y; Chen Y; Shen X; Zheng Y; Zhao Y
J Nanobiotechnology; 2023 Feb; 21(1):70. PubMed ID: 36855156
[TBL] [Abstract][Full Text] [Related]
22. Effects of Muscone on the Expression of P-gp, MMP-9 on Blood-Brain Barrier Model In Vitro.
Wang GY; Wang N; Liao HN
Cell Mol Neurobiol; 2015 Nov; 35(8):1105-15. PubMed ID: 25976179
[TBL] [Abstract][Full Text] [Related]
23. Genetic variants of organic cation transporter 2 (OCT2) significantly reduce metformin uptake in oocytes.
Song IS; Shin HJ; Shin JG
Xenobiotica; 2008 Sep; 38(9):1252-62. PubMed ID: 18728938
[TBL] [Abstract][Full Text] [Related]
24. Organic Cation Transporter (OCT/OCTN) Expression at Brain Barrier Sites: Focus on CNS Drug Delivery.
Betterton RD; Davis TP; Ronaldson PT
Handb Exp Pharmacol; 2021; 266():301-328. PubMed ID: 33674914
[TBL] [Abstract][Full Text] [Related]
25. Notoginsenoside R1 intervenes degradation and redistribution of tight junctions to ameliorate blood-brain barrier permeability by Caveolin-1/MMP2/9 pathway after acute ischemic stroke.
Liu B; Li Y; Han Y; Wang S; Yang H; Zhao Y; Li P; Wang Y
Phytomedicine; 2021 Sep; 90():153660. PubMed ID: 34344565
[TBL] [Abstract][Full Text] [Related]
26. Expression of organic cation transporters OCT1 (SLC22A1) and OCT3 (SLC22A3) is affected by genetic factors and cholestasis in human liver.
Nies AT; Koepsell H; Winter S; Burk O; Klein K; Kerb R; Zanger UM; Keppler D; Schwab M; Schaeffeler E
Hepatology; 2009 Oct; 50(4):1227-40. PubMed ID: 19591196
[TBL] [Abstract][Full Text] [Related]
27. P-Glycoprotein Aggravates Blood Brain Barrier Dysfunction in Experimental Ischemic Stroke by Inhibiting Endothelial Autophagy.
Huang L; Chen Y; Liu R; Li B; Fei X; Li X; Liu G; Li Y; Xu B; Fang W
Aging Dis; 2022 Oct; 13(5):1546-1561. PubMed ID: 36186136
[TBL] [Abstract][Full Text] [Related]
28. Genetic variation in organic cation transporters and considerations in drug development.
Varma MVS
Expert Opin Drug Metab Toxicol; 2023 Mar; 19(3):149-164. PubMed ID: 37070463
[TBL] [Abstract][Full Text] [Related]
29. Enhanced Intestinal Permeability and Plasma Concentration of Metformin in Rats by the Repeated Administration of Red Ginseng Extract.
Jin S; Lee S; Jeon JH; Kim H; Choi MK; Song IS
Pharmaceutics; 2019 Apr; 11(4):. PubMed ID: 31003498
[TBL] [Abstract][Full Text] [Related]
30. Development of Human in vitro Brain-blood Barrier Model from Induced Pluripotent Stem Cell-derived Endothelial Cells to Predict the in vivo Permeability of Drugs.
Li Y; Sun X; Liu H; Huang L; Meng G; Ding Y; Su W; Lu J; Gong S; Terstappen GC; Zhang R; Zhang W
Neurosci Bull; 2019 Dec; 35(6):996-1010. PubMed ID: 31079318
[TBL] [Abstract][Full Text] [Related]
31. Reduced antidiabetic effect of metformin and down-regulation of hepatic Oct1 in rats with ethynylestradiol-induced cholestasis.
Jin HE; Hong SS; Choi MK; Maeng HJ; Kim DD; Chung SJ; Shim CK
Pharm Res; 2009 Mar; 26(3):549-59. PubMed ID: 19002567
[TBL] [Abstract][Full Text] [Related]
32. AIM2 deletion enhances blood-brain barrier integrity in experimental ischemic stroke.
Xu SY; Bian HJ; Shu S; Xia SN; Gu Y; Zhang MJ; Xu Y; Cao X
CNS Neurosci Ther; 2021 Oct; 27(10):1224-1237. PubMed ID: 34156153
[TBL] [Abstract][Full Text] [Related]
33. Targeting organic cation transporters at the blood-brain barrier to treat ischemic stroke in rats.
Stanton JA; Williams EI; Betterton RD; Davis TP; Ronaldson PT
Exp Neurol; 2022 Nov; 357():114181. PubMed ID: 35905840
[TBL] [Abstract][Full Text] [Related]
34. Houttuynia cordata extract increased systemic exposure and liver concentrations of metformin through OCTs and MATEs in rats.
You BH; Chin YW; Kim H; Choi HS; Choi YH
Phytother Res; 2018 Jun; 32(6):1004-1013. PubMed ID: 29480578
[TBL] [Abstract][Full Text] [Related]
35. Sulfenamide derivatives can improve transporter-mediated cellular uptake of metformin and induce cytotoxicity in human breast adenocarcinoma cell lines.
Markowicz-Piasecka M; Huttunen J; Sikora J; Huttunen KM
Bioorg Chem; 2019 Jun; 87():321-334. PubMed ID: 30913467
[TBL] [Abstract][Full Text] [Related]
36. Imatinib Uptake into Cells is Not Mediated by Organic Cation Transporters OCT1, OCT2, or OCT3, But is Influenced by Extracellular pH.
Blanc Mettral J; Faller N; Cruchon S; Sottas L; Buclin T; Schild L; Choong E; Nahimana A; Decosterd LA
Drug Metab Lett; 2019; 13(2):102-110. PubMed ID: 30734690
[TBL] [Abstract][Full Text] [Related]
37. Selective Inhibition on Organic Cation Transporters by Carvedilol Protects Mice from Cisplatin-Induced Nephrotoxicity.
Guo D; Yang H; Li Q; Bae HJ; Obianom O; Zeng S; Su T; Polli JE; Shu Y
Pharm Res; 2018 Sep; 35(11):204. PubMed ID: 30191328
[TBL] [Abstract][Full Text] [Related]
38. Transporter-Mediated Delivery of Small Molecule Drugs to the Brain: A Critical Mechanism That Can Advance Therapeutic Development for Ischemic Stroke.
Williams EI; Betterton RD; Davis TP; Ronaldson PT
Pharmaceutics; 2020 Feb; 12(2):. PubMed ID: 32075088
[TBL] [Abstract][Full Text] [Related]
39. Effect of Pharmaceutical Excipients on Intestinal Absorption of Metformin via Organic Cation-Selective Transporters.
Ruan Y; Li X; You L; Chen J; Shen Y; Zhang J; Yuan Y; Kang L; Qin C; Wu C
Mol Pharm; 2021 Jun; 18(6):2198-2207. PubMed ID: 33956455
[TBL] [Abstract][Full Text] [Related]
40. A co-culture-based model of human blood-brain barrier: application to active transport of indinavir and in vivo-in vitro correlation.
Megard I; Garrigues A; Orlowski S; Jorajuria S; Clayette P; Ezan E; Mabondzo A
Brain Res; 2002 Feb; 927(2):153-67. PubMed ID: 11821009
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
